Stages II-III Breast Cancer

Dose-Dense Chemotherapy with Ellence®, Cytoxan®, and Taxol® May Improve Survival in Node-Positive Breast Cancer (04-30-2015)

Patients with early-stage node-positive breast cancer who receive dose-dense adjuvant chemotherapy with Ellence® (epirubicin), Cytoxan® (cyclophosphamide), and Taxol® (paclitaxel) may have improved disease-free survival. These findings were released... Continue Reading

Herceptin Superior to Tykerb for Treatment of HER2-positive Breast Cancer (03-24-2015)

In patients with human epidermal growth factor receptor (HER2)–positive advanced breast cancer, the combination of Herceptin® (trastuzumab) plus a taxane resulted in delayed time to cancer progression and was associated with fewer side effects than... Continue Reading

Breast Cancer Research: Have We Made Progress? (01-27-2015)

Published results from research studies in breast cancer in the last year represent several practice changing milestones. CancerConnect News coverage of advances in the management of breast cancer included the following key developments: 2014: Have we... Continue Reading

Study Confirms Role of Ovarian Suppression and Aromasin for Younger Women With Hormone-sensitive Breast Cancer (12-19-2014)

Ovarian suppression combined with the anti-estrogen drug Aromasin® (exemestane) appears to greatly reduce the risk of breast cancer recurrence in younger women according to the results of the Suppression of Ovarian Function Trial (SOFT) presented at... Continue Reading

Breast Cancer Patients Are Now Living Longer without Relapse (12-18-2014)

Survival without relapse for patients with early-stage breast cancer has improved significantly over the past 30 years, particularly among women with HER2-positive disease. These findings were recently published in the Journal of Clinical Oncology. Cancer... Continue Reading

Exercise Significantly Reduces Joint Pain Caused by Hormone Therapy Taken by Patients With Breast Cancer (12-12-2014)

According to a study published this week in the Journal of Clinical Oncology regular exercise helps relieve arthritic joint pain associated with aromatase inhibitor (AI) drugs used to treat breast cancer.1 Aromatase inhibitors are widely used in the treatment... Continue Reading

German Study Demonstrate Significant Pathological Complete Response for Abraxane® in Early Stage Breast Cancer (12-11-2014)

Doctors from Germany reported the results of a clinical trial at the San Antonio Breast Cancer Symposium (SABCS) demonstrating that Abraxane®(nab-paclitaxel) is superior to conventional solvent-based paclitaxel for the treatment of women with early high-risk... Continue Reading

Walk or Run Your Way to a Reduced Risk of Breast Cancer (09-24-2014)

Want to reduce your risk of breast cancer? Lace up those shoes and get moving—because exercise has a significant impact. There is a growing body of evidence to indicate that exercise is crucial to reducing the risk of cancer. Now a new study has put... Continue Reading

Breast Conservation Therapy May Be Better than a Mastectomy (09-17-2014)

Breast cancer claims the lives of approximately 40,000 women annually in the United States alone. Early-stage breast cancer refers to cancer that has not spread from its site of origin. Patients with early-stage breast cancer have a high cure rate with... Continue Reading

Vaccine Derived from HER2 Protein May Help Prevent Breast Cancer Recurrence (09-16-2014)

A new breast cancer vaccine that is derived from the HER2 protein may help prevent recurrence in patients with HER2-positive disease and appears safe. Phase II study results of the vaccine were released at the 2014 Breast Cancer Symposium, September 4–6,... Continue Reading

« Previous PageNext Page »